News

Zacks Investment Research on MSN

Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System

Microbot Medical Inc. MBOT recently received FDA 510(k) clearance for its LIBERTY Endovascular Robotic System, marking a ...
Nasdaq

Microbot (MBOT) Inks a New Agreement to Begin Trial on LIBERTY

Microbot Medical Inc. MBOT recently signed a clinical trial agreement with the Baptist Hospital of Miami for its LIBERTY Endovascular Robotic Surgical System. The company has received the ...

REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

Microbot Medical Inc. (NASDAQ: MBOT) is a breakthrough medical device company focused on transforming endovascular procedures through advanced robotic technology. Microbot’s LIBERTY ® Endovascular ...
Seeking Alpha

Microbot Medical rises as robotic surgical system succeeds in pivotal trial

Shares of Microbot Medical (NASDAQ:MBOT) rose in the premarket on Wednesday after the MedTech firm announced that a pivotal trial for its Liberty endovascular surgical robotic system reached the ...

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.

Microbot Medical Inc.: Microbot Medical Receives FDA 510(k) Clearance for Its LIBERTY Endovascular Robotic System

Accelerated Launch Readiness Plans Position Company for Commercialization during Q4 2025 The Company's Initial Addressable Market Includes Approximately 2.5 Million Peripheral Endovascular Procedures ...